Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parvalbumins | 11 | 2022 | 250 | 1.370 |
Why?
|
| Prosencephalon | 6 | 2016 | 303 | 1.040 |
Why?
|
| Wakefulness | 13 | 2022 | 1245 | 1.000 |
Why?
|
| Rodentia | 2 | 2020 | 261 | 0.750 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2020 | 1004 | 0.730 |
Why?
|
| Arousal | 5 | 2022 | 1165 | 0.650 |
Why?
|
| Sleep | 12 | 2021 | 4623 | 0.640 |
Why?
|
| Carbohydrates | 1 | 2020 | 394 | 0.620 |
Why?
|
| Neurons | 12 | 2022 | 9338 | 0.570 |
Why?
|
| Acoustic Stimulation | 2 | 2020 | 1216 | 0.570 |
Why?
|
| Sleep Deprivation | 7 | 2009 | 832 | 0.480 |
Why?
|
| Theta Rhythm | 1 | 2013 | 207 | 0.400 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1071 | 0.400 |
Why?
|
| Indenes | 1 | 2012 | 57 | 0.400 |
Why?
|
| Sleep, REM | 6 | 2019 | 595 | 0.390 |
Why?
|
| Rats | 21 | 2021 | 24260 | 0.370 |
Why?
|
| Choline O-Acetyltransferase | 2 | 2014 | 150 | 0.370 |
Why?
|
| Cholinergic Agents | 2 | 2021 | 93 | 0.340 |
Why?
|
| Raphe Nuclei | 3 | 2006 | 104 | 0.320 |
Why?
|
| Sleep Stages | 4 | 2016 | 686 | 0.320 |
Why?
|
| Polysomnography | 4 | 2009 | 1776 | 0.320 |
Why?
|
| Disorders of Excessive Somnolence | 2 | 2008 | 271 | 0.320 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2018 | 8301 | 0.320 |
Why?
|
| Glutamate Decarboxylase | 4 | 2014 | 245 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2009 | 575 | 0.290 |
Why?
|
| Locus Coeruleus | 2 | 2022 | 176 | 0.280 |
Why?
|
| Receptors, Neuropeptide | 3 | 2013 | 111 | 0.280 |
Why?
|
| Motor Cortex | 2 | 2013 | 986 | 0.270 |
Why?
|
| Midline Thalamic Nuclei | 1 | 2004 | 13 | 0.260 |
Why?
|
| Triazoles | 2 | 2021 | 911 | 0.250 |
Why?
|
| Adenosine | 5 | 2018 | 825 | 0.250 |
Why?
|
| Neuronal Plasticity | 1 | 2013 | 1422 | 0.250 |
Why?
|
| Animals | 40 | 2022 | 168757 | 0.250 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 2 | 2021 | 54 | 0.240 |
Why?
|
| Electroencephalography | 14 | 2020 | 6150 | 0.240 |
Why?
|
| Piperidines | 3 | 2021 | 1602 | 0.230 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2013 | 1432 | 0.230 |
Why?
|
| Brain Chemistry | 1 | 2007 | 981 | 0.230 |
Why?
|
| Cell Membrane | 1 | 2013 | 3748 | 0.220 |
Why?
|
| Hippocampus | 5 | 2006 | 3675 | 0.220 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2013 | 1813 | 0.220 |
Why?
|
| gamma-Aminobutyric Acid | 5 | 2022 | 1121 | 0.200 |
Why?
|
| Septum of Brain | 1 | 2000 | 18 | 0.190 |
Why?
|
| Septal Nuclei | 1 | 2001 | 85 | 0.190 |
Why?
|
| Animal Feed | 1 | 2020 | 110 | 0.180 |
Why?
|
| Pons | 1 | 2001 | 245 | 0.180 |
Why?
|
| Avoidance Learning | 1 | 2021 | 233 | 0.180 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2013 | 1222 | 0.170 |
Why?
|
| Mice | 19 | 2022 | 81183 | 0.170 |
Why?
|
| Maze Learning | 3 | 2012 | 478 | 0.170 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2019 | 170 | 0.170 |
Why?
|
| Delta Rhythm | 1 | 2019 | 78 | 0.170 |
Why?
|
| Thalamic Nuclei | 1 | 2019 | 114 | 0.160 |
Why?
|
| Microdialysis | 5 | 2016 | 158 | 0.160 |
Why?
|
| Antipsychotic Agents | 1 | 2012 | 3057 | 0.160 |
Why?
|
| Evoked Potentials, Auditory | 2 | 2019 | 525 | 0.160 |
Why?
|
| Glutamic Acid | 2 | 2021 | 1169 | 0.160 |
Why?
|
| Motor Activity | 2 | 2010 | 2714 | 0.150 |
Why?
|
| Attention | 5 | 2022 | 2400 | 0.150 |
Why?
|
| Somatostatin | 1 | 2019 | 459 | 0.150 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2018 | 153 | 0.150 |
Why?
|
| Gene Knock-In Techniques | 3 | 2013 | 418 | 0.140 |
Why?
|
| Brain Waves | 2 | 2019 | 401 | 0.140 |
Why?
|
| Glutamates | 1 | 2017 | 398 | 0.130 |
Why?
|
| Action Potentials | 3 | 2017 | 1806 | 0.130 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 9734 | 0.120 |
Why?
|
| Neural Pathways | 3 | 2012 | 2972 | 0.120 |
Why?
|
| Schizophrenia | 3 | 2020 | 6882 | 0.120 |
Why?
|
| Auditory Perception | 1 | 2019 | 569 | 0.120 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2018 | 449 | 0.120 |
Why?
|
| Parasympathetic Nervous System | 1 | 2014 | 141 | 0.110 |
Why?
|
| Disease Models, Animal | 7 | 2012 | 18029 | 0.110 |
Why?
|
| Tegmentum Mesencephali | 1 | 2013 | 59 | 0.110 |
Why?
|
| Patch-Clamp Techniques | 4 | 2018 | 964 | 0.110 |
Why?
|
| Electromyography | 4 | 2016 | 1379 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 4 | 2014 | 2088 | 0.100 |
Why?
|
| Memory | 2 | 2019 | 2174 | 0.100 |
Why?
|
| Psychomotor Performance | 3 | 2008 | 1901 | 0.100 |
Why?
|
| Cell Count | 2 | 2009 | 1856 | 0.100 |
Why?
|
| Serotonin | 2 | 2006 | 1017 | 0.100 |
Why?
|
| Alzheimer Disease | 1 | 2012 | 8037 | 0.100 |
Why?
|
| Darkness | 1 | 2010 | 167 | 0.090 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 5708 | 0.090 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2012 | 440 | 0.090 |
Why?
|
| Male | 25 | 2019 | 350118 | 0.090 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2009 | 112 | 0.080 |
Why?
|
| Brain | 3 | 2012 | 26385 | 0.080 |
Why?
|
| Presenilin-1 | 1 | 2012 | 635 | 0.080 |
Why?
|
| Reticular Formation | 1 | 2008 | 61 | 0.080 |
Why?
|
| Rats, Inbred F344 | 4 | 2010 | 862 | 0.080 |
Why?
|
| Prefrontal Cortex | 2 | 2011 | 2147 | 0.080 |
Why?
|
| Plaque, Amyloid | 1 | 2012 | 729 | 0.080 |
Why?
|
| Physical Stimulation | 1 | 2009 | 525 | 0.080 |
Why?
|
| Neuropeptides | 3 | 2010 | 942 | 0.080 |
Why?
|
| Acetylcholine | 2 | 2022 | 621 | 0.070 |
Why?
|
| Pyramidal Cells | 1 | 2009 | 363 | 0.070 |
Why?
|
| Narcolepsy | 1 | 2009 | 195 | 0.070 |
Why?
|
| Cognition Disorders | 2 | 2012 | 4043 | 0.070 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2012 | 1121 | 0.070 |
Why?
|
| Dimethylphenylpiperazinium Iodide | 1 | 2005 | 6 | 0.070 |
Why?
|
| Spatial Behavior | 1 | 2006 | 90 | 0.070 |
Why?
|
| Space Perception | 1 | 2009 | 475 | 0.070 |
Why?
|
| Time Factors | 5 | 2012 | 40075 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 1655 | 0.070 |
Why?
|
| Ketamine | 1 | 2011 | 500 | 0.070 |
Why?
|
| Carbachol | 2 | 2017 | 226 | 0.070 |
Why?
|
| Discrimination Learning | 1 | 2007 | 280 | 0.060 |
Why?
|
| Eye Movements | 1 | 2008 | 507 | 0.060 |
Why?
|
| Long-Term Potentiation | 1 | 2006 | 293 | 0.060 |
Why?
|
| Afferent Pathways | 1 | 2004 | 302 | 0.060 |
Why?
|
| Nicotinic Agonists | 1 | 2005 | 271 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2009 | 4217 | 0.060 |
Why?
|
| Receptors, GABA-A | 2 | 2022 | 627 | 0.060 |
Why?
|
| Luminescent Proteins | 2 | 2017 | 853 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2010 | 2915 | 0.060 |
Why?
|
| Behavior, Animal | 2 | 2010 | 1881 | 0.050 |
Why?
|
| Nucleus Accumbens | 1 | 2005 | 366 | 0.050 |
Why?
|
| Immunohistochemistry | 3 | 2014 | 11366 | 0.050 |
Why?
|
| Memory Disorders | 1 | 2009 | 1184 | 0.050 |
Why?
|
| Diet | 1 | 2020 | 7939 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2007 | 6365 | 0.050 |
Why?
|
| Executive Function | 1 | 2010 | 1364 | 0.050 |
Why?
|
| Animals, Genetically Modified | 2 | 2017 | 1549 | 0.050 |
Why?
|
| Axonal Transport | 1 | 2001 | 177 | 0.050 |
Why?
|
| Nicotine | 1 | 2005 | 681 | 0.050 |
Why?
|
| Dentate Gyrus | 1 | 2001 | 160 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2022 | 909 | 0.040 |
Why?
|
| Exercise Test | 1 | 2007 | 2074 | 0.040 |
Why?
|
| Mesencephalon | 1 | 2001 | 329 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 1 | 2012 | 3587 | 0.040 |
Why?
|
| Purinergic P2 Receptor Agonists | 1 | 2018 | 14 | 0.040 |
Why?
|
| Homeostasis | 1 | 2010 | 3340 | 0.040 |
Why?
|
| Membrane Potentials | 2 | 2014 | 1137 | 0.040 |
Why?
|
| Purinergic P2 Receptor Antagonists | 1 | 2018 | 71 | 0.040 |
Why?
|
| Amygdala | 1 | 2006 | 1315 | 0.040 |
Why?
|
| Appetitive Behavior | 2 | 2008 | 37 | 0.040 |
Why?
|
| Receptors, Glutamate | 1 | 2018 | 232 | 0.040 |
Why?
|
| Reaction Time | 3 | 2008 | 2097 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 315 | 0.040 |
Why?
|
| Sodium Channel Blockers | 1 | 2017 | 176 | 0.030 |
Why?
|
| Tetrodotoxin | 1 | 2017 | 259 | 0.030 |
Why?
|
| Thalamus | 1 | 2022 | 1023 | 0.030 |
Why?
|
| Biological Assay | 1 | 2019 | 652 | 0.030 |
Why?
|
| Apoptosis | 1 | 2012 | 9727 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2007 | 2624 | 0.030 |
Why?
|
| Cholinergic Antagonists | 1 | 2016 | 165 | 0.030 |
Why?
|
| Muscarinic Agonists | 1 | 2014 | 87 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 2017 | 690 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2018 | 824 | 0.030 |
Why?
|
| Receptors, Muscarinic | 1 | 2014 | 156 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2001 | 1917 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 3505 | 0.030 |
Why?
|
| Lysine | 1 | 2017 | 1007 | 0.030 |
Why?
|
| Photoperiod | 1 | 2013 | 136 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 2025 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2017 | 1767 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 913 | 0.030 |
Why?
|
| Models, Animal | 1 | 2018 | 2171 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2017 | 2726 | 0.020 |
Why?
|
| Benzamides | 1 | 2017 | 1379 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 21827 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 2019 | 1162 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 39050 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2019 | 14557 | 0.020 |
Why?
|
| Receptor, Adenosine A1 | 1 | 2009 | 44 | 0.020 |
Why?
|
| Synaptic Membranes | 1 | 2009 | 91 | 0.020 |
Why?
|
| Microinjections | 1 | 2010 | 327 | 0.020 |
Why?
|
| Rats, Transgenic | 1 | 2009 | 72 | 0.020 |
Why?
|
| Data Collection | 1 | 2019 | 3341 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2016 | 2025 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2011 | 813 | 0.020 |
Why?
|
| Ion Channels | 1 | 2014 | 1056 | 0.020 |
Why?
|
| Humans | 8 | 2020 | 744343 | 0.020 |
Why?
|
| Dog Diseases | 1 | 2009 | 138 | 0.020 |
Why?
|
| Theophylline | 1 | 2008 | 132 | 0.020 |
Why?
|
| Mutation | 1 | 2012 | 29786 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2007 | 235 | 0.020 |
Why?
|
| Interneurons | 1 | 2011 | 577 | 0.020 |
Why?
|
| Reversal Learning | 1 | 2007 | 60 | 0.020 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 895 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 1538 | 0.020 |
Why?
|
| Locomotion | 1 | 2008 | 378 | 0.020 |
Why?
|
| Receptors, Presynaptic | 1 | 2005 | 15 | 0.020 |
Why?
|
| 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2005 | 32 | 0.020 |
Why?
|
| Color Perception | 1 | 2007 | 213 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2009 | 647 | 0.020 |
Why?
|
| Nicotinic Antagonists | 1 | 2005 | 96 | 0.020 |
Why?
|
| Corticosterone | 1 | 2006 | 310 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 2429 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2017 | 2942 | 0.020 |
Why?
|
| Smell | 1 | 2007 | 244 | 0.020 |
Why?
|
| Female | 5 | 2019 | 380194 | 0.020 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2005 | 152 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1866 | 0.020 |
Why?
|
| Dogs | 1 | 2009 | 3912 | 0.020 |
Why?
|
| Cognition | 2 | 2012 | 6770 | 0.010 |
Why?
|
| Memory, Short-Term | 1 | 2010 | 975 | 0.010 |
Why?
|
| Citalopram | 1 | 2005 | 403 | 0.010 |
Why?
|
| Receptors, Nicotinic | 1 | 2005 | 497 | 0.010 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2010 | 944 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 3848 | 0.010 |
Why?
|
| Emotions | 1 | 2012 | 2661 | 0.010 |
Why?
|
| Learning | 1 | 2010 | 1713 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 4462 | 0.010 |
Why?
|
| Proteomics | 1 | 2012 | 3638 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 7722 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 13881 | 0.010 |
Why?
|
| Oxygen | 1 | 2009 | 4189 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2013 | 13033 | 0.010 |
Why?
|
| Motivation | 1 | 2007 | 1971 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2010 | 6993 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 19905 | 0.010 |
Why?
|
| Genomics | 1 | 2012 | 5720 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 16365 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 10943 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2005 | 5021 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 15540 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 17446 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 23403 | 0.010 |
Why?
|
Concepts
(219)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_